Clindamycin Phosphate
FDA recalls
4 rows
| Date | Company and reason |
|---|---|
| Aug 5, 2026 | Baxter Healthcare Corporation CGMP Deviations |
| Nov 25, 2025 | Sun Pharmaceutical Industries Inc Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. |
| Mar 14, 2019 | Pfizer Inc. Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point |
| Jun 3, 2013 | Pharmacia & Upjohn LLC Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial. |
← Back to Clindamycin Phosphate
Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).